Bionano Genomics (BNGO) Non Operating Income (2017 - 2026)
Bionano Genomics' (BNGO) quarterly Non Operating Income came in at -$396000.0 in Q1 2026, down 107.8% year-on-year from $5.1 million in Q1 2025, and up 16.28% quarter-over-quarter from -$473000.0 in Q4 2025.
Bionano Genomics (BNGO) Non Operating Income (2017 - 2026) Analysis & Trends
Bionano Genomics has disclosed Non Operating Income across 10 years of filings, most recently posting -$396000.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at -$396000.0, down 107.8% year-over-year; the trailing twelve-month figure through Mar 2026 was -$135000.0 (up 95.59% YoY), and the FY2025 annual result was $5.9 million, up 173.74% from the prior year.
- Non Operating Income came in at -$396000.0 for Q1 2026 at Bionano Genomics, up from -$473000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $5.1 million in Q1 2025 to a low of -$16.9 million in Q4 2023.
- The 5-year median for Non Operating Income is -$33000.0 (2022), against an average of -$1.1 million.
- Peak annual rise in Non Operating Income reached 13600.0% in 2023, while the deepest fall reached 2672.82% in 2023.
- Bionano Genomics' Non Operating Income stood at $655000.0 in 2022, then sank by 2672.82% to -$16.9 million in 2023, then jumped by 51.44% to -$8.2 million in 2024, then jumped by 94.22% to -$473000.0 in 2025, then gained by 16.28% to -$396000.0 in 2026.
- The last three Non Operating Income figures came in at -$396000.0 (Q1 2026), -$473000.0 (Q4 2025), and -$219000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 85.10 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 86.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -131.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -1.37 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -200,000.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -4.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.02 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -6.00 Mn |
| 10 | Bionano Genomics | 14.01 Mn | -366,620.40 | 3.25 Mn | -396,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -396,000.00 |
| Dec 31, 2025 | -473,000.00 |
| Sep 30, 2025 | -219,000.00 |
| Jun 30, 2025 | 953,000.00 |
| Mar 31, 2025 | 5.08 Mn |
| Dec 31, 2024 | -8.18 Mn |
| Sep 30, 2024 | -321,000.00 |
| Jun 30, 2024 | 363,000.00 |
| Mar 31, 2024 | -1.36 Mn |
| Dec 31, 2023 | -16.85 Mn |
| Sep 30, 2023 | 685,000.00 |
| Jun 30, 2023 | 359,000.00 |
| Mar 31, 2023 | 745,000.00 |
| Dec 31, 2022 | 655,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | -38,000.00 |
| Mar 31, 2022 | -33,000.00 |
| Dec 31, 2021 | -955,000.00 |
| Sep 30, 2021 | -67,000.00 |
| Jun 30, 2021 | -15,000.00 |